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cer has been associated with changes in the balance of certain trace elements. In the present study
we aimed to investigate the levels of trace elements like calcium, copper, iron and zinc in colon can-
cer patients in comparison with healthy controls. Serum samples were collected from 256 colon can-
cer patients and 180 healthy age and sex matched controls. Trace element levels were detected using
commercially available kits and an Auto-Analyzer (ChemWell 2910, Awareness Technology, and
USA). The concentrations of calcium, copper and iron were not signiﬁcantly different in patients
in comparison with healthy controls. The concentration of zinc was signiﬁcantly lower in colon can-
cer patients (p= 0.001) as compared to normal subjects. Deﬁciency of zinc may play a role in the
development of colon cancer or may contribute to damage already underway. Zn may represent an
independent risk factor for colon cancer and therefore a possible target for prevention.
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lsevier1. Introduction
Although, the risk factors do not fully explain variations in the
incidence of complex disorders generally in cancer and colon
cancer in particular. Epidemiological studies have implicated
perturbations in the trace elements in the etiology of a number
of diseases including cancer. Trace elements are essential for
numerous metabolic and physiological processes in the body
(Merz, 1981). Therefore, imbalances in the optimum levels of
trace elements may affect biological processes and have been
associated with many diseases including heart autoimmune,
cancer, renal failure and neurological disorders (Dar et al.,
2008; Fuster et al., 1992; Shokrzadeh et al., 2009). Most of
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of trace elements like magnesium (Mg), copper (Cu), zinc (Zn),
calcium (Ca), iron (Fe) etc. Mn, Zn, Fe and Cu accomplish
decisive functions in maintaining human health and play an
important role in the synthesis and structural stabilization of
both proteins and nucleic acids. These elements are incorpo-
rated into the enzymes and complex carbohydrates e.g., Cu
is a cofactor for numerous enzymes and plays an important
role in development (Desai and Kaler, 2008). Zinc is important
for the functioning of more than 300 enzymes from all six en-
zyme classes and some of them are related with DNA and
RNA synthesis (Vallee et al., 1991; Tudor et al., 2005; Vallee
and Falchuk, 1993). It has a vital role in immune system and
is essential for the optimal function of a variety of physiolog-
ical and biochemical processes (Tudor et al., 2005). Based on
the bioinformatics estimates it has been reported that 10%
of the proteome contain Zn binding motives (Andreini et al.,
2006). Iron, apart from its presence in all body cells, is the
most abundant transition metal found in several tissues. It is
involved in many processes including DNA, RNA and protein
synthesis. Low serum iron has been reported in a variety of
motor disorders (Peralta et al., 1994). Copper is an important
trace metal which plays a fundamental role in the biochemistry
of the human system. It is an important component of several
metalloenzymes including tyrosine and dopamine hydroxylase
(Livesay, 2003). Copper has been suggested to play an impor-
tant role in several disorders (Wallwork, 1987). Calcium apart
from being vital for healthy teeth and bones plays a crucial role
in the functioning of nerves and muscle tissue.
A number of studies carried have shown that dietary cal-
cium intake is associated with a reduced incidence of colon
cancer among middle-aged subjects. These observations sug-
gest that alterations in essential trace elements like Cu, Fe,
Zn and Ca may play an important role in the pathogenesis
of complex diseases including colon cancer. Very few reports
are available on the concentration of these trace elements in
colon cancer patients. This work was under taken to estimate
the levels of trace elements like Ca, Cu, Fe and Zn in serum of
colon cancer patients in comparison with healthy controls. The
analyses of these trace elements may have a prognostic signif-
icance for colon cancer.
2. Subjects and methods
2.1. Study subjects
The study consisted of 256 colon cancer patients (males: fe-
males = 176:80) from University Hospital. Informed consent
was obtained from all the subjects included in the study. The
study was approved by the ethical Committee of the study hos-
pital. Each patient was examined by a qualiﬁed oncologist to
conﬁrm the diagnosis. Patients were differentiated by com-
puted tomography scans and magnetic resonance imaging.
One hundred and eighty healthy individuals matched for sex
and age formed control group (males:females = 124:56). They
were recruited simultaneously from the same demographic
area. Information on demographic characteristics and risk fac-
tors were collected by using a structural questionnaire. Risk
factors included hypertension, diabetes, and smoking. Accord-
ing to joint National Committee VI-VII, hypertension was de-
ﬁned as a systolic blood pressure >140 mm Hg and/or a
diastolic blood pressure >90 mm Hg based on the averageof the two blood pressure measurements, or a patient’s self-re-
ported history of hypertension or antihypertensive use, sup-
ported by documents (Britoy and Bystroya, 2003). Diabetes
was diagnosed if fasting plasma glucose was >110 mg/
100 ml or patient was on ant diabetic medication
(Radhakrishnamurthy, 2003). Smokers were deﬁned as those
reporting daily smoking. Ex-smokers and occasional smokers
were classiﬁed as non-smokers (Glader et al., 2000).3. Collection of blood samples and trace element analysis
Venous blood (5 ml) was collected from patients as well as con-
trols after overnight fasting, into a metal free plastic tube and
allowed to clot at room temperature for 1 h. Then the blood
sample was centrifuged at 3000 rpm for 15 min at room tem-
perature to separate the serum. The serum was aliquoted into
micro centrifuge tubes and stored at 80 C until analysis. Zn
and Fe were analyzed using kits obtained from Centronic
Gmbh, Germany and Ca and Cu were analyzed by kits from
Chema Diagnostisa, Italy. The sample pretreatment was car-
ried out according to the instructions of the kit manufacturer.
The measurement principle for the different trace elements
is as follows:
Calcium: Arsenazo (III) combines with calcium at slight
acidic pH to form a blue complex, the absorbance of which
is measured at 660 nm. The reaction has high speciﬁcity and
interference from Mg is avoided due to pH (Leary et al., 1992).
Copper: 3,5-Di-Br-PAESA combines with Cu (II) to form a
blue–violet complex, the absorbance is measured at 580 nm.
The reaction has high speciﬁcity and interference from other
cations is avoided, due to speciﬁc pH and environment (Abe
et al., 1989).
Iron: Fe ions are dissociated from its carrier protein, trans-
ferring in an acid medium and simultaneously reduced to fer-
rous state. The ferrous ions react with chromogen nitro-PAPS
to a color-complex highly speciﬁc. The absorbance is measured
at 578 nm and is directly proportional to the iron content
(Makino et al., 1988).
Zinc: Zn forms a red chelate complex with 2-(5-bromo-
pyridylazo)-5-(npropyl-N-sulphopropylamino)-phenol. The
absorbance is measured at 560 nm and is proportional to the
concentration of total zinc in the sample (Johansen and
Eliassonn, 1987).
3.1. Statistical analysis
The results were expressed as mean ± SD by using Sigma stat
(Windows Version 11.5) software. The analytical data was sub-
jected to one way ANOVA using the same software. The sig-
niﬁcance was set at P< 0.05.4. Results
During the study period, 256 colon cancer patients and 180
controls were included in the study. The demographic data
of the patients and controls has been presented in Table 1.
Mean age was 48 years in the former group and 47 years in
the latter. Hypertension was the most common risk factor fol-
lowed by diabetes, and smoking. Risk factor proﬁle of colon
cancer patients revealed hypertension in 71%, diabetes in
43%, smoking in 45% and family history of colon cancer in
Table 2 Trace element levels in colon cancer patients and
controls.
Colon cancer
patients
mean ± SD
Healthy
control
mean ± SD
One way
ANOVA
Calcium level (lg/dl) 13.10 ± 8.86 9.81 ± 6.26 P= 0.070
Iron level (lg/dl) 33.23 ± 47.60 40.71 ± 67.94 P= 0.544
Copper level (lg/dl) 154.60 ± 91.71 152.08 ± 112.56 P= 0.760
Zinc level (lg/dl) 65.39 ± 61.01 117.14 ± 63.27 P 6 0.001
Table 1 Demographic features of colon cancer patients and
controls.
Patients
(n= 256) (%)
Controls
(n= 180) (%)
Age (mean ± SD) 48.53 (16.34) 47.01 (17.78)
Male:female 176:80 124:56
Hypertension 71 50
Diabetes 43 31
Smokers 45 40
Family history of
colon cancer
25 12
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30% were diabetic, 40% smokers and 12% had family history
of colon cancer. Serum trace elements concentrations are pre-
sented in Table 2. The mean Ca level of the colon cancer pa-
tients was 13.10 lg/dl, which was more than the mean Ca
level of the healthy controls (9.81 lg/dl) but did not reach sta-
tistical signiﬁcance. Fe and Cu levels of colon cancer patients
were not signiﬁcantly different in comparison with the healthy
volunteers (P> 0.05). Only serum concentration of Zn was
decreased signiﬁcantly (P< 0.001) in colon cancer patients
compared to that of controls. The mean Zn level in patients
was 65.39 lg/dl and in controls it was117.14 lg/dl.
5. Discussion
The present work was designed to determine the level of trace
elements in colon cancer patients and compare these with
healthy controls. Changes in trace elements have been exam-
ined in many diseases like cardiovascular diseases, Diabetes,
neurological disorders and cancers (Shokrzadeh et al., 2009;
Desai and Kaler, 2009; Waggoner et al., 1999). Changes in
trace element levels may have prognostic signiﬁcance in com-
plex disorders including colon cancer. A number of molecular
roles for the trace elements like Fe and Zn have been identiﬁed
in differentiation and apoptosis (Emel et al., 2005). Similarly
Ca has been shown to play a primary role in the development
of cell injury in different pathological states of vital organs.
Disturbances of calcium homeostasis may be induced in three
different sub cellular compartments including cytoplasm, mito-
chondria or the endoplasmic reticulum (Wulf, 2000). Accord-
ing to the traditional calcium hypothesis the cell injury is
induced by a marked increase in cytoplasmic calcium activity
during stress. In fact injury has been shown to be associated
with both increase and decrease in cytoplasmic calcium activity
(Cuajungco and Lees, 1997). This shows that any signiﬁcantmodiﬁcation of trace element status might lead to the disease
development. The basis for the pathology induced by these
trace elements is under investigation. Several mechanisms have
been proposed. Some investigators proposed that although
these substances may not initiate damage, changes in their lev-
els may contribute to damage already underway (Marniemi
et al., 2005).
In the present study the levels of Ca, Fe and Cu were not
signiﬁcantly different in colon cancer patients in comparison
with healthy controls. Although Ca levels seemed to be high
in colon cancer patients, it did not reach statistical signiﬁcance.
Patients also tended to show low iron concentrations in com-
parison with healthy controls although devoid of statistical sig-
niﬁcance. Marniemi et al. (2005) have reported that low serum
Fe concentrations proved indicative of increased risk for both
acute myocardial infarction (Arnaud et al., 1994). Serum Zn
levels were signiﬁcantly reduced in colon cancer patients
(P< 0.001). The serum Zn levels have been reported to de-
crease within ﬁrst three days after acute myocardial infarction
(Katayama et al., 1990). Further, Katayama et al. (1990) have
reported that prognosis seemed to be much worse in those pa-
tients whose serum Zn concentrations were remarkably de-
creased with 12 h from admission (Chandra et al., 1994). Zn
has a key role to play in the several body functions because
it participates in the superoxide dismutase and Zn-thionine en-
zymes to reduce oxidative stress (Forte et al., 2005).
The decreased levels in serum Zn in colon cancer patients
may be due to the mobilization of circulating Zn to the colon
cancer tissue and its involvement in the antioxidant defense
since the patients might be under higher oxidative stress. Zn
is an essential cofactor in a variety of enzymes and has antiox-
idant-like properties. Therefore, it can stabilize macromole-
cules against radical induced oxidation in vitro as well as
limit excess radical production (Dhalla et al., 1999). A lower
level of zinc can also aid in the deterioration of cancer affected
colon tissue causing additional damage. In our colon cancer
patients also there was a trend for higher copper levels. How-
ever, it was not signiﬁcantly different in comparison with the
healthy volunteers. Zn levels have also been shown to be signif-
icantly low in some cancers (Dar et al., 2008). Therefore, trace
element deﬁciency or excess may be implicated in the develop-
ment or progression of colon cancer. The present study point
towards a role of trace element imbalance, especially Zn in
the colon cancer. However, is it a direct cause–effect relation-
ship or a consequence remains a big question? Further studies
are warranted to determine whether change in serum Zn may
represent an independent risk factor for the development of
colon cancer and in turn a possible target for preventive
intervention.
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